Search

everythinglearnresearchcommunity

for

Search:↓

Pulse electric fields can control the release of growth factors and serotonin from platelet-rich plasma, offering a tailored approach to wound healing.

Female pattern hair loss greatly harms women's mental health and social life.

rPanglaoDB helps study rare cell types by merging RNA data, confirming fibrocytes' role in healing.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Lichen planus pigmentosus is hard to treat and may be more common in North Africa than previously thought.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

10% hPL is best for growing mesenchymal stem cells, while 10% FBS is best for hepatocytes.

FGF signaling is crucial for starting feather development in chicken embryos.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Combining PRP with lipofilling shows promise for tissue regeneration but needs more clinical trials to confirm benefits.

Electric pulses can effectively activate platelets and release growth factors, offering a better alternative to traditional methods.

PRF may offer better healing and recovery than PRP for immediate implants.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

White lupin uses specific genes to grow root hairs and access phosphorus when it's scarce.

Fibrosing alopecia in a pattern distribution is a type of hair loss that may often be overlooked, especially in men.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Injectable platelet-rich fibrin has improved healing and regeneration in various medical fields and can be more effective than previous treatments.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

The combined treatment is more effective and safer for improving sunken acne scars.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Lichen planopilaris can be accurately diagnosed and effectively treated.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Finasteride and low-level laser therapy are similarly effective for frontal pattern hair loss.

PLLA dermal fillers can cause hair loss, but it can be treated with steroids.

Blood count parameters are not reliable for predicting recurrent implantation failure.

Periodontal ligament stem cells show promise for regrowing tissues but require more research for safe, effective use.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.